Navigation Links
Galderma Completes Tender Offer for CollaGenex
Date:4/7/2008

ted with rosacea and other skin disorders. CollaGenex recently acquired the rights to develop and commercialize becocalcidiol, a patented Vitamin D analogue that is currently in Phase II clinical trials for the topical treatment of mild to moderate psoriasis.

For more information on CollaGenex please visit CollaGenex's website at http://www.collagenex.com, which does not form part of this press release.

Forward Looking Statements

Statements in this press release regarding management's future expectations, beliefs, intentions, goals, strategies, plans or prospects may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by terminology such as "anticipate," "believe," "could," "could increase the likelihood," "estimate," "expect," "intend," "is planned," "may," "should," "will," "will enable," "would be expected," "look forward," "may provide," "would" or similar terms, variations of such terms or the negative of those terms. Such forward-looking statements involve known and unknown risks, uncertainties and other factors including those risks, uncertainties and factors referred to in the Company's Quarterly Report on Form 10-K for the year ended December 31, 2007 filed with the Securities and Exchange Commission under the section "Risk Factors," as well as other documents that may be filed by CollaGenex from time to time with the Securities and Exchange Commission as well as related to the satisfaction of the closing conditions in the merger agreement. As a result of such risks, uncertainties and factors, the Company's actual results may differ materially from any future results, performance or achievements discussed in or implied by the forward-looking statements contained herein. CollaGenex is providing the information in this press release as of this date and assumes no obligations to up
'/>"/>

SOURCE Galderma Pharma S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals
2. ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic
3. Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
4. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
5. Galderma Associates Itself to Cartiers Womens Initiative Awards to Recognize Female Entrepreneurs From Around the Globe
6. ProGenTech Completes $21 Million Series C Financing
7. KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K
8. Payformance Completes Sale of Corporate Payments Division
9. PreMD Inc. Completes Debenture Financing
10. Gentiva(R) Health Services Completes Acquisition of Major Home Health Provider in CON State of Mississippi
11. Roche Completes Tender Offer for Ventana Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... (PRWEB) May 29, 2015 News: 2015-2016 ... , Company website: http://www.carsonenergy.com , In ... rapidly, due to the boom in US shale production ... in order to regain market share from US shale ... realized by putting more oil out into the marketplace, ...
(Date:5/29/2015)... Wimbledon Health Partners, the leading on-site ... and NCV testing, is proud to announce the ... EKG interpretation of athletes. , Sudden cardiac ... athletic activity. New findings presented in February have played ... cardiac safety in athletes. Physiologic adaptations in athletic individuals ...
(Date:5/29/2015)... Thursday, May 21st was the inaugural Red Nose ... of life came together to raise money for kids living ... campaign dedicated to raising money for children and young people ... laugh, the people at Hands-On Seminars decided to host their ... provided food, fun and laughter to their visitors, while raising ...
(Date:5/29/2015)... Belviq for weight loss , also ... medication. In 2012, the FDA approved Belviq specifically ... BMI >30. It is also approved for individuals ... weight-related health condition such as high blood pressure, diabetes, ... for weight loss focuses on the brain’s appetite center. ...
(Date:5/28/2015)... External Counterpulsation (EECP/ECP) has been used extensively all ... There are a growing number of people with advanced ... angina and these patients are often times not amenable ... “No option” patients are a sizable cohort of population ... considered unacceptable for heart stent or bypass. The Heart ...
Breaking Medicine News(10 mins):Health News:Breaking News: Carson Energy Releases 2015-2016 Oil Forecast 2Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 2Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 3Health News:Groups, such as Hands-On Physical Therapy, Across the Country, Host Their Own Events and Make the Inaugural Red Nose Day a Huge Success 2Health News:Belviq for Weight Loss is Now Available to Qualified Diet Doc Patients Nationwide 2Health News:Belviq for Weight Loss is Now Available to Qualified Diet Doc Patients Nationwide 3Health News:External Counterpulsation (EECP/ECP) a New Heart Disease Therapy Helps People of Calgary with Unstable Angina 2
... BioSpecifics,Technologies Corp. (OTC Bulletin Board: BSTC.OB), a biopharmaceutical,company ... BioSpecifics, President, Tom Wegman, will present a,corporate overview ... Healthcare,Conference on Wednesday, November 12, 2008, at 10:20am ... York, NY., A live webcast of the ...
... Nov. 7 Eric Abrue (30), a,quadriplegic patient who is ... a historic and highly successful LASIK procedure performed,by Drs. Jeffrey ... in a,playground in 1986, breaking his neck and severing his ... unable to move any,part of his body below his upper ...
... Power and Associates Also Names Kaiser Permanente "Highest ... DENVER, Nov. 7 Kaiser Permanente Colorado is ... plan in,Colorado according to a joint ranking by ... for Quality Assurance (NCQA)., To view the ...
... Study finds these doctors have better results, including survival ... heart surgeons may be the best choice for adults ... new study suggests. , A congenital heart defect occurs ... blood vessels near the heart. , The researchers analyzed ...
... Children under the age of three who had hernia surgery ... later compared to children who had not undergone the surgery, ... School of Public Health and the College of Physicians and ... into the New York State Medicaid system between 1999 and ...
... Show at Nassau Coliseum, NEW YORK, Nov. 7 ... 2009 Concert Series -- a Valentine,s Day show,with Barry Manilow, ... will be held on February 14th, 2009 at Nassau Coliseum, ... 10th at 10am,through Ticketmaster.com or by calling Stand Up for ...
Cached Medicine News:Health News:Historic LASIK Surgery Performed on Quadriplegic Patient to Preserve his Communication Abilities 2Health News:Audio: Kaiser Permanente is Colorado's Top Commercial and Medicare Plan on U.S. News & World Report/NCQA 'America's Best Health Plans' List 2Health News:Audio: Kaiser Permanente is Colorado's Top Commercial and Medicare Plan on U.S. News & World Report/NCQA 'America's Best Health Plans' List 3Health News:Pediatric Heart Surgeons May Be Best Choice for Adults 2Health News:General anesthesia for hernia surgery in children and risk of later developmental problems 2Health News:Barry Manilow Brings Valentine's and Music to New York With Concert to Raise Funds for Breast Cancer Research 2
(Date:5/28/2015)... DIEGO , May 28, 2015   ... clinical-stage biopharmaceutical company leveraging its molecular adhesion and ... for sickle cell disease, heart failure, and arterial ... resigning from the Company,s Board of Directors. Mr. ... conflict of interest given his role as President ...
(Date:5/28/2015)... , May 28, 2015  Transportation Insight, ... announces winning the SDCE100 Award for the ... Demand Chain Executive magazine. Transportation Insight ... goods distributor quantify and control supply chain ... highly competitive market. Deploying Transportation Insight,s Enterprise ...
(Date:5/28/2015)... -- National Community Pharmacists Association (NCPA) CEO B. ... in response to a new report released ... number of generic drug costs increased substantially in 2013: ... expressed by NCPA and underscores the need for action ... Moreover, a 2015 survey of 700 community pharmacists concluded ...
Breaking Medicine Technology:Mast Therapeutics Announces Change In Board Of Directors 2Mast Therapeutics Announces Change In Board Of Directors 3Mast Therapeutics Announces Change In Board Of Directors 4Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 2Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 3Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 4NCPA: AARP Drug Pricing Report Reiterates Need for Fair Generic Drug Reimbursements 2
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that ... present a company update at the Cowen Health Care Conference in ... Interested parties may access a live audio webcast of ... www.BMRN.com .  A replay of the call will be archived ...
... 2011 Uptake Medical ® Corp., a developer of ... emphysema , announced today that Scott Huennekens, President and ... ) has joined the company,s Board of Directors. ... Volcano since April 2002. He led the company from a ...
Cached Medicine Technology:BioMarin to Present at the Cowen Health Care Conference 2Uptake Medical Announces Scott Huennekens Elected to Board of Directors 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: